Blog
Clinical Technology Outlook 2026–2030: From Isolated Measurements to Continuous, Connected Care
Clinical technology is entering a new phase. For decades, healthcare has largely been organized around isolated encounters: a blood-pressure measurement during an office visit, a laboratory panel drawn at a single moment, an image captured after symptoms appear, or a bedside assessment documented periodically during hospitalization.
Those measurements remain essential. But they offer snapshots of biological systems that are continuously changing.
The clinical technology outlook for 2026 through
…
Sep 17th 2026
TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program
PRESS RELEASE
TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program
For Immediate ReleaseSeptember 2, 2026TruWay Health — News & Insights
New prospective observational platform will investigate longitudinal physiologic trajectories using multimodal ultrasound, artificial intelligence, and privacy-preserving federated learning
NEW YORK — September 2, 2026 — TruWay Health today announced the formal release of TH-OMNIPHYS-20
…
Sep 2nd 2026
Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health
PRESS RELEASE
Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health
NEW YORK — September 1, 2026 — Truway Health today announced the release of its prospective observational research protocol, TH-CLINICAL-TIME-2026-001, titled “Clinical Time and Temporal Dynamics Study (CLINICAL-TIME)”, establishing a long-term research framework to investigate how changes
…
Sep 1st 2026
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration
News & Insights | September 1, 2026
TruWay Health is advancing FUSION-72: Multimodal Digital Biomarker Prediction of Acute Deterioration, a research initiative conducted under TH-FUSION72-2026-001.
The study is focused on an emerging area of clinical research: understanding whether combinations of digital biomarkers and longitudinal clinical signals can help identify patterns associate
…
Sep 1st 2026
Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study
FOR IMMEDIATE RELEASE
Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study
Prospective observational study will evaluate whether a locked computational model can characterize and predict multisystem recovery in approximately 450 adults
NEW YORK — September 1, 2026 — Truway Health, Inc. today announced that the protocol record for the Truway Whole-Body Digital Twin and Physiologic Resilience Study, known as TRU-OMNIBODY, has been released throug
…
Aug 31st 2026